Labcorp

Complaints & Reviews on USAComplaints

USAComplaints currently maintains 57 historical complaints about Labcorp, published between 2002 and 2013. No approved complaints have been published on this site during the last three years. For a current reputation snapshot, see the independent sources below.

• Consumer ReportPublished May 24, 2013 · Historical consumer allegation
• Consumer ReportPublished Feb 14, 2013 · Historical consumer allegation
• Fraudulent billing practicesPublished Dec 16, 2012 · Historical consumer allegation
• Rule of the specimen collection manPublished Dec 5, 2012 · Historical consumer allegation
• ReceptionistPublished Nov 19, 2012 · Historical consumer allegation
• Lost my job due to labcorpPublished Oct 31, 2012 · Historical consumer allegation
• Lack of company doing their joPublished Aug 23, 2012 · Historical consumer allegation
• Laboratory Corporation of America My Credit Card Used by LabCorp without my Knowledge!Published Jun 29, 2012 · Historical consumer allegation
• Horrible ServicePublished Jun 14, 2012 · Historical consumer allegation
• Horrible Customer ServicePublished May 21, 2012 · Historical consumer allegation
• U.S. Labs, Integrated Oncology, LabCorp LabCorp Guilty of Stealing & Extortion!Published May 8, 2012 · Historical consumer allegation
• Credit Card Charge Required for Guaranteed ServicesPublished Feb 24, 2012 · Historical consumer allegation
• Medical testingPublished Dec 8, 2011 · Historical consumer allegation
• Labcorp signifacnat overchargePublished Dec 8, 2011 · Historical consumer allegation
• Consumer ReportPublished Oct 20, 2011 · Historical consumer allegation
• Deceived Bill from LabCorp North CarolinaPublished Aug 28, 2011 · Historical consumer allegation
• Rude staffPublished Jun 15, 2011 · Historical consumer allegation
• Very Rude StaffPublished May 24, 2011 · Historical consumer allegation
• Terminated and screwed for getting hurtPublished Apr 13, 2011 · Historical consumer allegation
• Injury/Fraudulent BillingPublished Mar 8, 2011 · Historical consumer allegation

Independent Sources

Shown for context — not merged with USAComplaints' own numbers.

Contacts, Payment & Login

• Official website: https://www.labcorp.com/
• Patient Billing team (payment plans, disputes): 800-845-6167 11 complaints mention this number
• Bill Pay & Insurance: https://patient.labcorp.com/invoices/find
• Labcorp Patient Portal: https://patient.labcorp.com/ui/
• Corporate fax (BBB listing): 336-436-1775

Locations

Have a Labcorp bill or test-result problem? What to check

BBB complaints reviewed for this profile include bills for tests patients did not recognize, wrong-patient billing, and insurance-coding or claim-denial disputes. These are consumer allegations and case-specific billing disputes, not findings that any particular bill was fraudulent.

• Start with Labcorp's own Billing & Insurance help. Labcorp's patient help center explains: "You have several convenient options to set up a payment plan: You can create a payment plan that works for you through your MyLabcorp™ mobile app or online using your Labcorp Patient™ portal… Call our Patient Billing team directly at 800-845-6167, available Monday through Friday, 8:00 a.m. to 5:00 p.m. ET."
• If a bill lists a provider or a test you don't recognize, ask Labcorp in writing (through the Patient Portal or the Patient Inquiry form) to confirm the date of service, the ordering provider, and the specific test performed before you pay or dispute it with your insurer.
• If you think you were "balance billed" or hit with a surprise bill, Labcorp's own Balance Billing & No Surprises Act page explains your federal protections: emergency care and certain services at an in-network facility generally can't be balance-billed above your plan's in-network cost-sharing. If you have employer self-funded (ERISA) coverage, Labcorp's page directs complaints to the federal government at cms.gov/nosurprises/consumers or by calling 1-800-985-3059; several states have their own additional balance-billing rules.
• If Labcorp has already sent an account to collections while you're disputing it, get the dispute and any refund/adjustment offer in writing, and ask Labcorp's billing team directly whether the collections placement can be paused pending resolution. If a third-party debt collector contacts you, the CFPB explains that disputing the debt in writing within the validation period generally requires the collector to stop collecting until it sends you verification — BBB complaint responses reviewed for this page show Labcorp sometimes issuing refunds or balance adjustments after a dispute is escalated through BBB.
• For a missing or delayed result (Labcorp says many tests are reported within 24 to 48 hours, some take up to two weeks, and specialized tests such as genetic tests may take up to 21 days; if more than two weeks have passed, it says delays are most often caused by outdated or inaccurate personal information), use the Labcorp Patient Portal or MyLabcorp app first, since Labcorp warns that ordinary email is not a secure way to receive results.
• Keep records of every call, the representative's name if given, and any reference or invoice numbers.
• If you are uninsured or paying yourself: Labcorp's Good Faith Estimate page says you can request an estimate at 855-522-2677, at least 3 days before the service (or when you schedule), and that if you receive a bill at least $400 more than your Good Faith Estimate you may dispute it. For help with surprise-billing rights under the No Surprises Act, CMS's medical bill rights help line is 1-800-985-3059.

Company background: from Laboratory Corporation of America Holdings to Labcorp Holdings Inc.

Labcorp's main operating subsidiary, Laboratory Corporation of America, has a Better Business Bureau file recording a business start date of 1971 and incorporation in January 1975; the BBB profile also lists earlier or acquired-brand names including Roche Biomedical Laboratories, Dianon, Esoterix, Dynacare Laboratories, and Genetica DNA Laboratories. According to Labcorp's own site, the company says it has "more than 71,000 employees across the globe" (its newer investor boilerplate says "nearly 70,000 employees") and, per its patient-facing pages, "more than 2,200 locations," is "trusted by over 400,000 physicians," and is "contracted with 700+ health plans nationwide."

Labcorp completed the spin-off of Fortrea on June 30, 2023 (the distribution was completed at 11:59 p.m. that day, per Labcorp's July 3, 2023 press release), its former contract-research/clinical-trials business, as an independent, separately traded company (NASDAQ: FTRE). Labcorp's own press release states: "Upon closing, Fortrea made a cash distribution to Labcorp of approximately $1.6 billion as partial consideration for the assets that Labcorp contributed to Fortrea in connection with the spin-off." Fortrea is now a separate public company and is not part of Labcorp.

On May 17, 2024, Labcorp completed a holding-company reorganization. Per its SEC Form 8-K: "Laboratory Corporation of America Holdings, a Delaware corporation (‘Labcorp’)… implemented the Reorganization… Merger Sub merged with and into Labcorp, with Labcorp continuing as the surviving corporation and a wholly owned subsidiary of Labcorp Holdings… Following the Merger, Labcorp Holdings became the successor issuer to Labcorp." The publicly traded parent is now legally named Labcorp Holdings Inc., a Delaware corporation, with Laboratory Corporation of America Holdings and Laboratory Corporation of America continuing beneath it as subsidiaries. Labcorp's SEC filings list its principal executive offices at 358 South Main Street, Burlington, North Carolina 27215, while its own Corporate Facts page lists its headquarters as 531 South Spring Street, Burlington, North Carolina 27215; the company trades on the NYSE under the ticker LH.

DOJ False Claims Act settlements and the 2019 AMCA data-breach settlement

Labcorp has resolved several federal False Claims Act matters in recent years. Except where noted, these are civil settlements of allegations, not findings or admissions of liability.

Urine drug testing ("ToxAssure Comprehensive"), $14,500,000, July 15, 2026. The Department of Justice's Office of Public Affairs announced that Labcorp agreed to pay $14.5 million to resolve allegations that it violated the False Claims Act "by submitting false claims to Medicare Part B… for medically unnecessary urine drug testing (UDT)… pursuant to a testing panel offered by Labcorp, called ‘Toxassure Comprehensive.’" Unusually, DOJ states that "as part of the settlement, Labcorp admitted, acknowledged, and accepted responsibility for the following facts": that from January 1, 2018 through November 22, 2023, it "routinely submitted claims for presumptive and definitive UDT to Medicare," running "many of these tests simultaneously for the same patient, on the same date of service, using the same urine sample," and billing both the all-inclusive presumptive code and the highest-tier definitive code each time. "has been credited in this settlement under the Department of Justice's guidelines for taking disclosure, cooperation and remediation into account in False Claims Act cases."

Phlebotomy services tied to HDL/Singulex referral-fee allegations, $19,000,000, February 7, 2023. The U.S. Attorney's Office for the District of South Carolina announced Labcorp agreed to pay $19 million resolving allegations that it "caused the submission of false claims to Medicare as a result of Labcorp's provision of phlebotomy services for patients whose health care providers were ordering laboratory testing from Labcorp, Health Diagnostic Laboratory, Inc. (HDL), and/or Singulex, Inc.… at a time when Relators allege Labcorp knew HDL and/or Singulex were paying health care providers process and handling fees as an inducement to refer patients." HDL and Singulex had previously separately settled their own liability for a combined $48.5 million. The case originated as a qui tam suit by relators Scarlett Lutz and Kayla Webster, who received about $5.6 million of the settlement; "the claims resolved by the settlement are allegations only, and there has been no determination of liability."

Department of Defense / GeneDx genetic-test overbilling, $2,100,000, March 27, 2023. The U.S. Attorney's Office for the District of Maryland announced Labcorp agreed to pay $2.1 million over allegations that, from December 1, 2013 through June 30, 2021, it "double and/or triple billed DoD for genetic tests performed by GeneDx" (a third-party reference lab), overcharged DoD for those tests, and billed for tests it could not later document with a requisition form, test result, or invoice. The qui tam relator, former Labcorp employee Donna Hecker-Gross, received $357,000; "the settlement is not an admission of liability by LabCorp."

Medicare "14-Day Rule" / Caris Life Sciences orders, $388,667.17, January 2, 2025. The U.S. Attorney's Office for the Eastern District of Tennessee announced that Laboratory Corporation of America Holdings, Laboratory Corporation of America, Labcorp Tennessee LLC, and University Health System, Inc. paid a combined $388,667.17 over allegations that, from March 2012 through November 2023, they "caused the delay of the submission of physician orders for Caris testing… until 14 days after a Medicare beneficiary's discharge… to circumvent Medicare's Date of Service Rule." The qui tam relator, Kim Vo, received $73,846.76; the claims are allegations only.

2019 AMCA data-breach multistate settlement, $2.3 million (44 states), announced September 24, 2026. A coalition of 44 attorneys general (including Connecticut's and Maryland's, whose releases are quoted here) announced a $2.3 million settlement ($2,287,455 to the states, per New Hampshire's release) resolving an investigation into "the 2019 data breach at Labcorp's debt collector, Retrieval-Masters Creditors Bureau d/b/a American Medical Collection Agency (‘AMCA’)." Connecticut's release states the breach "potentially exposed the personal information of over 27.5 million individuals throughout the United States, including 10.2 million Labcorp patients," of whom 43,666 were Connecticut residents and, per Maryland's release, 451,558 were Maryland residents; "the multistate coalition settled with AMCA in 2021 after the company's bankruptcy petition was dismissed." The releases note that although "the data breach occurred at AMCA, the data involved was the sensitive data of Labcorp's patients," and that "data security is a non-delegable duty" even when work is outsourced to a vendor.

Separately, in the consolidated federal case over the same breach, In re: American Medical Collection Agency, Inc., Customer Data Security Breach Litigation, MDL No. 2904 (D.N.J.), Labcorp agreed to a $35 million class-action settlement (Labcorp Track). After a Final Approval Hearing on August 20, 2026, Magistrate Judge Michael A. Hammer signed a Final Approval Order and Judgment the same day (Dkt. 940). The order states that about 11,825,034 potential class members were identified and sent notice, overrules the three objections filed, lists four exclusions, awards class counsel $11,900,000 in fees plus $2,813,558.90 in costs and $5,000 to each class representative, and dismisses the Labcorp-track claims with prejudice. It also states that neither the order nor the settlement is an admission of liability by Labcorp. The court-authorized settlement website lists the claim deadline as September 3, 2026, which has passed; questions about a claim already filed go to the settlement administrator through that website (amcadatabreachsettlement83395.com). This class settlement is separate from the $2.3 million payment to the states.

Complaint record: USAComplaints, BBB, and Trustpilot, reported separately

Several sources track complaints and reviews about Labcorp, and this page reports each separately rather than blending them into one figure:

• USAComplaints: 57 complaints about Labcorp (under names including Labcorp, LabCorp, Lab Corp, and Laboratory Corporation of America) are linked to this profile as of September 28, 2026, dated from 2002 to 2013.
• BBB (Laboratory Corporation of America, Burlington, NC headquarters profile, checked September 28, 2026): the business is not BBB accredited and carries a BBB Rating of F, with BBB's stated "Reasons for rating" being "Failure to respond to 29 complaint(s) filed against business" and "7 complaint(s) filed against business that were not resolved." BBB shows 562 complaints in the last three years (117 closed in the last 12 months), and a separate customer-review score of 1.01 out of 5 from 119 reviews. Examples in the BBB complaints reviewed for this page included billing sent to or for the wrong patient, insurance coding or claim-denial disputes, accounts sent to collections while a dispute was still open, and difficulty obtaining an itemized or HSA-eligible receipt; Labcorp's responses in the sampled complaints included refunds, invoice adjustments to zero or reduced balances, and explanations of its billing process.
• Trustpilot: an apparently unclaimed profile showing 1.4 out of 5 ("Bad") from 533 reviews; Trustpilot notes the company has "no history of asking for reviews," so the review set "may not be representative."

Because each source covers a different population, time window, and methodology, none of these figures is added to or averaged with any other.

The ADA kiosk class action: Laboratory Corp. of America Holdings v. Davis

Labcorp was the defendant in Davis v. Laboratory Corporation of America Holdings, a putative class action filed January 31, 2020 in the U.S. District Court for the Central District of California. Blind and visually impaired patients alleged that Labcorp’s self-service check-in kiosks were inaccessible to them. These were allegations, and the Supreme Court did not decide the underlying accessibility merits.

The U.S. Supreme Court considered whether a federal court may certify a damages class under Rule 23 when the class includes both injured and uninjured members. On June 5, 2025, in Laboratory Corp. of America Holdings v. Davis, 605 U.S. ___ (2025), the Court issued a per curiam opinion stating: "The Court dismisses the case as improvidently granted and therefore does not decide the question presented: Whether a federal court may certify a damages class pursuant to Federal Rule of Civil Procedure 23 when the class includes both injured and uninjured class members." Justice Kavanaugh dissented, writing: "I would resolve the question presented and reverse the judgment of the Ninth Circuit. I would hold that federal courts may not certify a damages class pursuant to Rule 23 when the class includes both injured and uninjured class members." The dismissal ("DIG") left the Ninth Circuit's class-certification ruling in place procedurally but decided no legal question and did not rule on whether Labcorp's kiosks actually violate the ADA; that underlying dispute was not resolved by the Supreme Court's action.

Is Labcorp Legitimate?

Labcorp Holdings Inc. is a large, publicly traded company (NYSE: LH) based in Burlington, North Carolina (its SEC filings list principal executive offices at 358 South Main Street; its Corporate Facts page lists headquarters at 531 South Spring Street), operating a nationwide network of more than 2,200 patient service centers through its subsidiary Laboratory Corporation of America. It has resolved multiple federal False Claims Act cases with the Department of Justice, including a July 2026 settlement in which it admitted specific billing facts about a urine-drug-testing panel, and a September 2026 multistate settlement over the 2019 AMCA data breach; in each case the underlying allegations, except where Labcorp admitted specific facts, were resolved without a determination of liability. It was also the defendant in a Supreme Court case over ADA-related class certification that the Court dismissed without deciding the underlying accessibility question. Patients with a billing question can reach Labcorp's Patient Billing team at 800-845-6167 or through the Labcorp Patient Portal. This page assigns Labcorp no rating, score, or "scam" label of its own; readers can weigh the regulatory, complaint, and litigation record above for themselves.

Court & Public Records

Company Relationships

• Affiliated with: Laboratory Corporation of America Holdings

Frequently Asked Questions